Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/5/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Philippe Halfon?

Philippe Halfon

Chief Executive Officer

AlphaBio Inc

HQ Phone:  (949) 858-4999

Direct Phone: +33 * ** ** ** **direct phone

Email: p***@***.fr

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

AlphaBio Inc

29816 Avenida De Las Banderas

Rancho Santa Margarita, California,92688

United States

Company Description

AlphaBio is focused on its developing ARTeSYS™ "Single Use" purification systems and on site services business with the divestment of its distribution business. This newly enabled focus will allow us to accelerate the innovation timelines and target areas that... more

Find other employees at this company (46)

Background Information

Employment History

Co-Founder and President

Genoscience Pharma


Affiliations

ACTGene Inc

Founder


Advanced Biological Laboratories SA

Member of - The Company - Scientific Advisory Board


Education

MD


Web References(27 Total References)


Management team - Genoscience pharma

www.genosciencepharma.com [cached]

Philippe Halfon, MD, PharmD, PhD, President and founder
Dr Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio, and GenosciencePharma. He completed a training in Oncogenetic and continue to have a consultation in oncogenetic and infectious Diseases in the European Hospital. He was recently appointed as Associate Professor in Paris Medical college


Press Releases

www.biolinerx.com [cached]

Professor Philippe Halfon, world-renowned scientist for his work on HIV, HPV (human papilloma virus causing cervical cancer) and Hepatitis, and a co-inventor of BL-8030, said, "BL-8030 has shown promising results in pre-clinical studies, and may become an important part of combination therapies for HCV.
BL-8030 was invented by Professor Philippe Halfon and his team at Genoscience, and co-developed with scientists at RFS Pharma, LLC. Prof. Halfon, Co-Founder and President of Genoscience, is a specialist in molecular virology and infectious diseases, especially HIV, HPV and Hepatitis. In addition he is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio and Genoscience.


www.news-medical.net

It was developed as an anti-viral therapy by Professor Philippe Halfon, Co-Founder and President of Genoscience and a world renowned scientist for his work on HIV (AIDS virus), HPV (human papilloma virus causing cervical cancer) and Hepatitis.
In addition, Prof. Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio and Genoscience.


Press Releases

biolinerx.com [cached]

It was developed as an anti-viral therapy by Professor Philippe Halfon, Co-Founder and President of Genoscience and a world renowned scientist for his work on HIV (AIDS virus), HPV (human papilloma virus causing cervical cancer) and Hepatitis.
In addition, Prof. Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio and Genoscience. "I am very pleased with BioLineRx's accelerated development program for BL-8020," said Prof. Philippe Halfon, Co-Founder and President of Genoscience.


Press Releases

www.biolinerx.com [cached]

BL-8030 was invented by Professor Philippe Halfon and his team at Genoscience and co-developed with assistance from scientists at RFS Pharma, LLC.
Prof. Halfon, Co-Founder and President of Genoscience, is a specialist in molecular virology and infectious diseases, especially HIV, HPV (Human Papilloma Virus) and Hepatitis. In addition he is the founder of several biotechnology companies focusing on antiviral drug discovery and development including ACTgene, Alphabio and Genoscience. Prof. Philippe Halfon said, "We were impressed by the drug development expertise of the BioLineRx team and are very pleased to collaborate with them on a second HCV project.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory